| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1859 | 2020 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 175 | 2021 |
| Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression L Casadei, F Calore, CJ Creighton, M Guescini, K Batte, OH Iwenofu, ... Cancer research 77 (14), 3846-3856, 2017 | 170 | 2017 |
| Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer S Kregel, JL Chen, W Tom, V Krishnan, J Kach, H Brechka, TB Fessenden, ... Oncotarget 7 (18), 26259, 2016 | 110 | 2016 |
| The emergence of genome-based drug repositioning YA Lussier, JL Chen Science translational medicine 3 (96), 96ps35-96ps35, 2011 | 90 | 2011 |
| Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression JL Chen, J Li, KJ Kiriluk, AM Rosen, GP Paner, T Antic, YA Lussier, ... Clinical Cancer Research 18 (16), 4291-4302, 2012 | 84 | 2012 |
| Chemoproteomics reveals Toll-like receptor fatty acylation NM Chesarino, JC Hach, JL Chen, BW Zaro, MVS Rajaram, J Turner, ... BMC biology 12, 1-13, 2014 | 75 | 2014 |
| TP53 mutational status is predictive of pazopanib response in advanced sarcomas K Koehler, D Liebner, JL Chen Annals of Oncology 27 (3), 539-543, 2016 | 71 | 2016 |
| Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures J Chen, L Sam, Y Huang, Y Lee, J Li, Y Liu, HR Xing, YA Lussier Journal of biomedical informatics 43 (3), 385-396, 2010 | 61 | 2010 |
| How essential are unstructured clinical narratives and information fusion to clinical trial recruitment? P Raghavan, JL Chen, E Fosler-Lussier, AM Lai AMIA Summits on Translational Science Proceedings 2014, 218, 2014 | 60 | 2014 |
| BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma ND Seligson, EA Kautto, EN Passen, C Stets, AE Toland, SZ Millis, ... The oncologist 24 (7), 973-979, 2019 | 56 | 2019 |
| FDG‐PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer JL Chen, DE Appelbaum, M Kocherginsky, CL Cowey, ... Cancer medicine 2 (4), 545-552, 2013 | 56 | 2013 |
| Network models of genome-wide association studies uncover the topological centrality of protein interactions in complex diseases Y Lee, H Li, J Li, E Rebman, I Achour, KE Regan, ER Gamazon, JL Chen, ... Journal of the American Medical Informatics Association 20 (4), 619-629, 2013 | 55 | 2013 |
| Complex-disease networks of trait-associated single-nucleotide polymorphisms (SNPs) unveiled by information theory H Li, Y Lee, JL Chen, E Rebman, J Li, YA Lussier Journal of the American Medical Informatics Association 19 (2), 295-305, 2012 | 52 | 2012 |
| Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance DH Ahn, M Javle, CW Ahn, A Jain, S Mikhail, AM Noonan, C Wu, ... Cancer 122 (23), 3657-3666, 2016 | 50 | 2016 |
| A multicenter phase II study of nivolumab+/-ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts. JL Chen, MR Mahoney, S George, CR Antonescu, DA Liebner, ... Journal of Clinical Oncology 38 (15_suppl), 11511-11511, 2020 | 44 | 2020 |
| Autophagy induction results in enhanced anoikis resistance in models of peritoneal disease JL Chen, J David, D Cook-Spaeth, S Casey, D Cohen, K Selvendiran, ... Molecular Cancer Research 15 (1), 26-34, 2017 | 43 | 2017 |
| Visually meaningful histopathological features for automatic grading of prostate cancer MKK Niazi, K Yao, DL Zynger, SK Clinton, J Chen, M Koyutürk, ... IEEE journal of biomedical and health informatics 21 (4), 1027-1038, 2016 | 41 | 2016 |
| Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures YA Lussier, WM Stadler, JL Chen Journal of the American Medical Informatics Association 19 (2), 156-160, 2012 | 37 | 2012 |
| Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma KLJ Bill, ND Seligson, JL Hays, A Awasthi, B Demoret, CW Stets, ... The oncologist 24 (7), 989-996, 2019 | 36 | 2019 |
John HaysAssociate Professor, The Ohio State University James Cancer Hospital在 osumc.edu 的电子邮件经过验证
